Skip to content

Study on Heart Failure Surveillance and Standards for the diagnosis and treatment (BJ-HFS)

Study on Heart Failure Surveillance and Standards for the diagnosis and treatment

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR-ERC-10000905
Enrollment
Unknown
Registered
2010-03-18
Start date
2006-02-01
Completion date
Unknown
Last updated
2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Heart failure

Interventions

Regular management:inform the standard treatment
undefined follow-up doctor
the state of therapy efficiency was decided by doctor himself
the follow-up results was uploaded by patients
Strengthen managent:Follow up by scheduled period, fixed hospital and doctor
standardized the guideline of medicine
trainning the follow-up patients

Sponsors

Fuwai Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1. Patients aged 18-80; 2. Heart failure patients with orginic heart diseases,including coronary heart disease, hypertension, operations after cardiomyopathy and Valvular heart disease; 3. Residents in Beijing; 4. Non-residents who can follow up regularly

Exclusion criteria

Exclusion criteria: 1. Non-residents who cannot follow up regularly; 2. Simple diastolic heart failure; 3. Right heat failure, COPD; 4. Severe hypertrophic obstructive cardiomyopathy, restrictive cardiomyopathy; 5. Pericardial disease, Pericardial tamponade, Constrictive pericarditis; 6. Valvular heart disease( before operation); 7. Congenital Heart Disease; 8. severe kidney disease (cc 265umol/L (>=3mg/dl); 9. Hepatic Dysfunction base on lab analysis; 10. unstable skull disease; 11. Malignancy; 12. Cognitive impairment, dementia, severe psychopath; 13. Patinets with severe physcial disablities; 14. Uncontrolled diseases from other systems; 15. Preparing or ongoing pregnacy; 16. Refuse to sign the informed consent.

Design outcomes

Primary

MeasureTime frame
all cause death; hospitalised due to hear failure; MI;

Secondary

MeasureTime frame
Success rate of therapy; NYHA; Quality of life; therapy cost;

Countries

China

Contacts

Public ContactYuejin Yang
yangyj1958@yahoo.com.cn+86 68331752

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026